Sebia
Brunhilde Dauphin is an experienced professional in quality management and research and development within the diagnostics and microbiology sectors. Currently serving as Responsable qualité projet et système at Sebia since April 2021, Brunhilde previously held the position of Research and Development Scientist at Beckman Coulter Diagnostics from October 2015 to April 2021, where involvement in a significant international microbiology project was highlighted. Prior experience includes Directrice des opérations at Andromas, with a successful record in obtaining CE-IVD certification for medical devices and leading project development for microorganism identification. Early career roles encompassed positions as Ingénieur microbiologie at Faculté de médecine, Paris Descartes, and Ingénieur d’étude oenologie at Faculté d’Oenologie de Bordeaux. Brunhilde's educational background includes a Master’s degree in life and health sciences with a specialization in oenology and microbiology, as well as ongoing doctoral research in analytical chemistry at AgroParisTech.
This person is not in any teams
This person is not in any offices
Sebia
2 followers
Our mission is to provide powerful tools that translate what is happening in a patients’ body into a readable and interpretable language. We call it our new language of life. The “language of life” makes it easier to understand, diagnose and treat chronic and metabolic diseases produced by the modern way of life. Cancer, obesity, aging and depression share a common biology: they are metabolic and inflammatory. Those pathological imbalances lead to protein modification which require special separation techniques to give us a better understanding. Capillary Electrophoresis (CE) is the most accurate and efficient method of separation to unlock these complex conditions. Sebia is a Global specialized In Vitro Diagnostic player and the world’s leading provider of clinical protein electrophoresis equipment and reagents for the screening and monitoring of various diseases, primarily in the areas of Oncology (Multiple Myeloma), Diabetes, Hemoglobinopathy and other rare pathologies. Headquartered in the South of Paris (Lisses, France), We set high standards in making continuous advances in CE technology, scientific excellence and manufacturing capabilities, providing Sebia the possibility to pursue diagnostic solutions with an exciting pipeline of new tests and automated equipment.